Escherichia coli is a major cause of bloodstream and urinary tract infections globally. The wide dissemination of multidrug-resistant (MDR) strains of extraintestinal pathogenic E. coli (ExPEC) poses a rapidly increasing public health burden due to narrowed treatment options and increased risk of failure to clear an infection. Here, we present a detailed population genomic analysis of the ExPEC ST131 clone, in which we seek explanations for its success as an emerging pathogenic strain beyond the acquisition of antimicrobial resistance (AMR) genes. We show evidence for evolution toward separate ecological niches for the main clades of ST131 and differential evolution of anaerobic metabolism, key colonization, and virulence factors. We further demonstrate that negative frequency-dependent selection acting across accessory loci is a major mechanism that has shaped the population evolution of this pathogen. IMPORTANCE Infections with multidrug-resistant (MDR) strains of Escherichia coli are a significant global public health concern. To combat these pathogens, we need a deeper understanding of how they evolved from their background populations. By understanding the processes that underpin their emergence, we can design new strategies to limit evolution of new clones and combat existing clones. By combining population genomics with modelling approaches, we show that dominant MDR clones of E. coli are under the influence of negative frequency-dependent selection, preventing them from rising to fixation in a population. Furthermore, we show that this selection acts on genes involved in anaerobic metabolism, suggesting that this key trait, and the ability to colonize human intestinal tracts, is a key step in the evolution of MDR clones of E. coli.

No abstract

ABSTRA ABSTRA ABSTRA ABSTRA ABSTRACT CT CT CT CT: R : R : R : R : Rapid detection of pathogenic and spoilage micr apid detection of pathogenic and spoilage micr apid detection of pathogenic and spoilage micr apid detection of pathogenic and spoilage micr apid detection of pathogenic and spoilage microor oor oor oor oorganisms is essential for ensur ganisms is essential for ensur ganisms is essential for ensur ganisms is essential for ensur ganisms is essential for ensuring the safety and ing the safety and ing the safety and ing the safety and ing the safety and quality of food. Real-time polymerase chain reaction (PCR) technology has the potential to achieve rapid, sensitive, quality of food. Real-time polymerase chain reaction (PCR) technology has the potential to achieve rapid, sensitive, quality of food. Real-time polymerase chain reaction (PCR) technology has the potential to achieve rapid, sensitive, quality of food. Real-time polymerase chain reaction (PCR) technology has the potential to achieve rapid, sensitive, quality of food. Real-time polymerase chain reaction (PCR) technology has the potential to achieve rapid, sensitive, and specific detection of these micr and specific detection of these micr and specific detection of these micr and specific detection of these micr and specific detection of these microor oor oor oor oorganisms in food. I ganisms in food. I ganisms in food. I ganisms in food. I ganisms in food. In this r n this r n this r n this r n this review eview eview eview eview, w , w , w , w , we discuss r e discuss r e discuss r e discuss r e discuss real-time PCR technologies in eal-time PCR technologies in eal-time PCR technologies in eal-time PCR technologies in eal-time PCR technologies in use today use today use today use today use today, applications of r , applications of r , applications of r , applications of r , applications of real-time PCR in food systems eal-time PCR in food systems eal-time PCR in food systems eal-time PCR in food systems eal-time PCR in food systems, and some of the associated challenges and limitations , and some of the associated challenges and limitations , and some of the associated challenges and limitations , and some of the associated challenges and limitations , and some of the associated challenges and limitations. . . . .

The identification of these lineages of E. coli and their shared genetic traits suggest there may be evolutionary events that underpin the emergence of carbapenem resistance plasmid carriage in E. coli.

MLL gene rearrangements (MLLr) are a common cause of aggressive, incurable acute lymphoblastic leukemias (ALL) in infants and children, most of which originate in utero. The most common MLLr produces an MLL-AF4 fusion protein. MLL-AF4 promotes leukemogenesis by activating key target genes, mainly through recruitment of DOT1L and increased histone H3 lysine-79 methylation (H3K79me2/3). One key MLL-AF4 target gene is PROM1, which encodes CD133 (Prominin-1). CD133 is a pentaspan transmembrane glycoprotein that represents a potential pan-cancer target as it is found on multiple cancer stem cells. Here we demonstrate that aberrant PROM1/CD133 expression is essential for leukemic cell growth, mediated by direct binding of MLL-AF4. Activation is controlled by an intragenic H3K79me2/3 enhancer element (KEE) leading to increased enhancer-promoter interactions between PROM1 and the nearby gene TAPT1. This dual locus regulation is reflected in a strong correlation of expression in leukemia. We find that in PROM1/CD133 non-expressing cells, the PROM1 locus is repressed by polycomb repressive complex 2 (PRC2) binding, associated with reduced expression of TAPT1, partially due to loss of interactions with the PROM1 locus. Together, these results provide the first detailed analysis of PROM1/CD133 regulation that explains CD133 expression in MLLr ALL.